GLP-1 Price Per Month Comparison: Wegovy, Zepbound, and New Oral Options

Trying to compare GLP 1 price per month can feel overwhelming—and expensive. Between Wegovy, Zepbound, and emerging oral alternatives, the cost differences can be massive—even for similar results.

Some patients pay over $1,000/month, while others access the same class of medications for a fraction of that price.

New oral GLP-1 options are also entering the market, offering alternative pricing and convenience for some patients.

But choosing the right option isn’t just about price—it’s about understanding how cost, effectiveness, and access all fit together.

Quick Answer: GLP-1 medications cost anywhere from $149 to over $1,000 per month in 2026, depending on which drug you take, whether you have insurance, and how you access it. Novo Nordisk’s DirectMeds self-pay option now starts at $199/month for Wegovy and Ozempic. Medicare MyStart GLP-1 patients pay around $245/month with a $50 copay cap. Uninsured cash-pay patients using the TrumpRx platform pay approximately $350/month. Prices are dropping fast, and there are more affordable pathways than most people realize. [1][2][3][4]

Key Takeaways

• GLP-1 price per month ranges from $149 (oral lowest dose) to $1,000+ (branded, no insurance) in 2026
• Novo Nordisk’s self-pay Wegovy and Ozempic now start at $199/month through direct programs [4]
• Medicare patients pay approximately $245/month with a $50 copay cap starting April 2026 [2]
• The TrumpRx platform offers GLP-1 injections at $350/month for cash-pay patients [3]
• Zepbound multi-dose pens are now priced at $299–$449/month through LillyDirect [4]
• Oral GLP-1 options (including oral Wegovy) start at $150/month for the lowest dose [4]
• Novo Nordisk announced a 50% list price cut on Wegovy coming in 2027, targeting $675/month [4]
• Commercial insurance coverage remains inconsistent — many patients still pay full price [3]
• Compounding pharmacies and telehealth platforms offer some of the lowest-cost access points
• Prices are actively falling — waiting even six months could mean significant savings

What Does GLP-1 Price Per Month Actually Look Like in 2026?

The GLP-1 price per month varies more than most people expect. In 2026, you’re not looking at one fixed number — you’re looking at a range that depends on your drug, your insurance status, and how you buy it.

Here’s a straightforward breakdown of what people are actually paying right now:

Medication	Standard List Price	Self-Pay / Direct Price	Medicare (Est.)
Wegovy (injectable)	$1,300+/month	$199/month (Novo direct) [4]	~$245/month [2]
Ozempic (injectable)	$900+/month	$199/month (Novo direct) [4]	~$245/month [2]
Zepbound (injectable)	$1,060+/month	$299–$449/month (LillyDirect) [4]	~$245/month [2]
Oral Wegovy (tablet)	TBD	~$150/month (lowest dose) [4]	TBD
TrumpRx GLP-1 program	N/A	$350/month [3]	N/A
Orforglipron (projected)	TBD	$149–$399/month (projected) [3]	TBD

The gap between the “sticker price” and what you actually pay is enormous. That’s the most important thing to understand before you assume GLP-1 medications are out of reach.

For a deeper look at semaglutide-specific pricing, check out this complete semaglutide cost breakdown with and without insurance.

Why Are GLP-1 Prices Dropping So Fast Right Now?

Several forces are pushing GLP-1 costs down simultaneously in 2026, and understanding them helps you time your access smartly.

Competition between Novo Nordisk and Eli Lilly is the biggest driver. After Eli Lilly’s Zepbound overtook Wegovy in sales in 2025, Novo Nordisk responded aggressively. On April 14, 2026, Novo announced it would cut list prices on its three GLP-1 medicines to $675/month by 2027 — a 50% reduction from Wegovy’s previous price. [4]

Government pricing pressure is the second major factor. The White House brokered direct pricing deals in November 2025. The TrumpRx platform launched as a direct-to-consumer option at $350/month, bypassing pharmacy benefit managers entirely. [3]

Medicare expansion created a new pricing floor. Starting April 2026, Medicare covers injectable GLP-1s for weight loss with a $50 monthly copay cap, with the government negotiating a base price of approximately $245/month. [2]

Oral GLP-1 options are adding competitive pressure from below. The FDA approved oral semaglutide for weight loss in late 2025, launching at $149–$150/month for the lowest dose. [4] That’s a price point that forces injectable manufacturers to compete.

The bottom line: if you were priced out of GLP-1 medications a year ago, the landscape looks meaningfully different today.

At a Glance: Top 3 Affordable GLP-1 Providers

Use this table to find the program that fits your specific medical and financial needs.

We have listed the “🥇 Gold Standard“, ” 🥈 Silver Standard“, and lastly the ” 🥉Bronze Standard” GLP-1 products of 2026 in the united states.

Service	Best For	Cost/(Mo.)	Key Feature	Medical Oversight
🥇 DirectMeds (Henry Meds)	Premium results on a budget	$297+	Most established telehealth provider	High-touch clinical support. Network of 600+ U.S. doctors
🥈MyStart GLP-1	Predictable flat-rate pricing	$254 (flat rate)	Price never increases with dosage	Includes physician & coaching
🥉MEDVi GLP-1	Absolute lowest cost	$99 – $399	Price-match guarantee, broad access	U.S. licensed doctors

The 3 Most Affordable GLP 1 Without Insurance (2026 Ranked)

🥇 #1 Best Overall: Zepbound (Triple-Action Option)

DirectMeds is a LegitScript-certified telehealth platform that connects patients with licensed U.S. physicians who evaluate whether compounded GLP-1 medications are clinically appropriate.

It is one of the most established providers in this space and is particularly well-suited to patients who want high-touch clinical oversight without paying brand-name prices.

How it works: Complete a secure online health intake form. A licensed medical provider reviews your profile and determines eligibility. If approved, your prescription is sent to a certified U.S. compounding pharmacy and medication is shipped directly to your door. All-inclusive pricing covers medical consultation, medication, and 24/7 support — no surprise charges.

◉ Clinical Note: DirectMeds’ LegitScript certification is a meaningful differentiator in this market. It requires compliance with pharmacy laws, prescription standards, and advertising guidelines — reducing the risk of receiving substandard compounded medications. For patients new to telehealth GLP-1 programs, this certification provides a meaningful layer of accountability. — Dr. Sarah Jenkins, Co-Author

🎯 Ideal for: Patients who want an established, verified provider with strong clinical support and are comfortable paying slightly more than the absolute floor price for greater peace of mind.

🥈#2 Best for Long-Term Cost Certainty: MyStart GLP-1

🥈 Silver Standard — Best Flat-Rate Pricing

👉 Check MyStart Eligibilit→

MyStart GLP-1 uses a unique flat-rate membership model where your medication cost is fixed regardless of how high your therapeutic dose increases over time. For patients who will be on GLP-1 therapy for 12 months or more, this pricing structure can save $600 to $1,800 annually compared to platforms that charge progressively more as doses escalate.

How it works: Pay a monthly membership ($79) plus a flat medication fee (e.g., $175 for compounded semaglutide). The combined total stays fixed at $254 per month from starter dose through maximum maintenance dose. Medical consultation, all medication, dedicated care team access, and nutritional coaching are included.

◉ Clinical Note: The flat-rate model is financially sound for long-term GLP-1 use. GLP-1 therapy is most effective when sustained for 12+ months, and avoiding dose-related price increases removes a common reason patients discontinue treatment early. The included nutritional coaching adds meaningful clinical value, as sustainable weight loss requires both medication and lifestyle change. — Dr. Sarah Jenkins, Co-Author

🎯 Ideal for: Patients committed to long-term treatment (12+ months) who want price certainty as doses increase, and who value behavioral coaching as part of their program.

Best for: People who want a more advanced GLP-1 approach at a reduced price. 👉 SKIP THE WAITLIST. START FOR $199

Thousands of people are losing weight with MyStart GLP-1 medications. People like you are transforming their lives, feeling better, and looking their best with the help of GLP-1 (Dual-Action Option) medications.

🥉 #3 Best for Absolute Lowest Entry Cost: MEDVi GLP-1

🥉 Bronze Standard — Lowest Entry Price

👉 Check MEDVi Eligibility→

MEDVi offers the most accessible entry price point in the compounded GLP-1 market, with starter doses beginning as low as $99 per month and a published price-match guarantee.

The platform provides both injectable and oral compounded GLP-1 options, giving prescribers flexibility to match the medication form to the patient. Clinical follow-up is primarily quarterly rather than monthly, which keeps costs lower but means less frequent dose adjustment guidance than the two options above.

How it works: Complete an online consultation. If qualified, your prescription is sent to a partner compounding pharmacy and medication is shipped to you within 48 hours. Customer support is available, and clinical check-ins are typically quarterly. No membership fees are charged on top of medication pricing.

◉ Clinical Note: MEDVi is a legitimate, cost-effective option for budget-focused patients who have researched compounded medications and are comfortable with less frequent clinical contact. Always ask your provider which specific compounding pharmacy fulfills your prescription — a reputable 503A or 503B state-licensed pharmacy is non-negotiable for safety. — Dr. Sarah Jenkins, Co-Author

🎯 Ideal for: Budget-focused patients who have done their research on compounded GLP-1 medications, are comfortable managing more of their own care independently, and want the lowest possible entry price with a price-match guarantee.

👉 START LOSING FOR $200 TODAY

How Does Insurance Affect Your GLP-1 Price Per Month?

Insurance coverage for GLP-1 medications is improving, but it’s still inconsistent and often frustrating. Here’s what the coverage landscape actually looks like in 2026.

Medicare: The clearest win. Medicare now covers injectable GLP-1s for weight loss with a $50/month copay cap. The base negotiated price sits around $245/month. [2] State Medicaid programs also have access to these pricing arrangements. [2] If you’re on Medicare, this is likely your best option.

Commercial insurance: Much murkier. While CMS indicated Most Favored Nation (MFN) pricing could extend to commercial plans, Eli Lilly clarified their agreement does not cover commercial insurance. [3] This means many privately insured patients still face high out-of-pocket costs or outright denials for weight loss indications.

Employer plans: Coverage varies widely. Some large employers cover GLP-1s; many don’t, especially for weight loss (as opposed to diabetes management). Ozempic is more commonly covered than Wegovy because it’s FDA-approved for type 2 diabetes.

What to do if your insurance denies coverage:

• Request a prior authorization appeal with documentation of BMI and comorbidities
• Ask your doctor to prescribe for a covered indication if applicable
• Explore manufacturer savings programs (Novo’s self-pay at $199/month, LillyDirect at $299+/month)
• Consider the TrumpRx platform at $350/month as a fallback [3]

For a step-by-step guide on navigating this, see how to get GLP-1 covered by insurance in 2026.

Common mistake: Many people assume their insurance covers GLP-1s and never check. Always verify your specific plan’s formulary before assuming coverage — and always ask whether the coverage applies to weight loss vs. diabetes management.

What Is the Cheapest Way to Get GLP-1 Medications Per Month?

The cheapest legitimate access points for GLP-1 medications in 2026, from lowest to highest cost:

1. Oral GLP-1 (lowest dose): ~$149–$150/month Oral semaglutide (oral Wegovy) launched at approximately $150/month for the lowest dose. [4] This is currently the most affordable branded GLP-1 entry point. Note: the lowest dose may not produce the same weight loss results as higher doses or injectable formulations.

2. Novo Nordisk self-pay program: $199/month Novo’s direct self-pay option for Wegovy and Ozempic at $199/month is a significant shift from previous pricing. [4] This reflects the company’s response to White House pricing deals and competitive pressure from Lilly. Access this through NovoCare or Novo’s direct patient programs.

3. Medicare with $50 copay cap: ~$245/month If you qualify for Medicare, this is a strong option. The $50 copay cap makes budgeting predictable. [2]

4. TrumpRx platform: $350/month The government-backed direct-to-consumer platform targets cash-pay patients at $350/month for GLP-1 injections. [3] This bypasses pharmacy benefit managers and is designed for people without adequate insurance coverage.

5. LillyDirect (Zepbound): $299–$449/month Zepbound’s starter dose dropped to $299/month through LillyDirect, with other doses at $449/month. [4] If tirzepatide works better for you metabolically, this is competitive pricing.

6. Compounding pharmacies (with caution) Compounding pharmacies have offered semaglutide and tirzepatide at significantly lower prices — sometimes $100–$200/month. However, the FDA has moved to restrict compounded GLP-1 availability as branded shortages resolve. Always verify legitimacy before using a compounding pharmacy. See our guide on how to verify a legitimate compounding pharmacy.

For a comprehensive look at the lowest-cost options, our cheapest GLP-1 medications guide for 2026 covers every current pathway in detail.

How to Access GLP-1 Medications at the Lowest Price: Step-by-Step

Getting the best GLP-1 price per month isn’t complicated, but it does require a few deliberate steps.

Step 1: Confirm you’re a candidate GLP-1 medications are generally prescribed for adults with a BMI of 30+, or BMI 27+ with a weight-related condition like type 2 diabetes, hypertension, or sleep apnea. Talk to your doctor or use a telehealth platform for an initial consultation.

Step 2: Check your insurance coverage first Before paying out of pocket, verify your plan’s formulary. Call your insurer directly and ask: “Is [specific GLP-1 medication] covered for weight management under my plan, and what is my copay?” This single call can save you hundreds of dollars monthly.

Step 3: If insured — get a prior authorization Most insurers require prior authorization for GLP-1s. Your doctor’s office handles this, but you may need to follow up. Document your BMI, any comorbidities, and prior weight loss attempts to strengthen the case.

Step 4: If uninsured or denied — compare direct-pay options

• Novo’s $199/month self-pay program (Wegovy/Ozempic)
• LillyDirect at $299–$449/month (Zepbound)
• TrumpRx at $350/month [3]
• Oral semaglutide at ~$150/month for the starter dose [4]

Step 5: Use a telehealth provider for convenience and cost Telehealth platforms often bundle the consultation, prescription, and medication fulfillment at competitive prices. Some platforms include the medication cost in a monthly subscription. See our DirectMeds review for GLP-1 semaglutide without insurance for one example.

Step 6: Reassess every 3–6 months Prices are actively changing. The $199/month Novo option didn’t exist a year ago. Novo’s 2027 price cuts to $675/month on list price will likely trigger further competitive drops. Check in regularly — your best option today may not be your best option in six months.

Is the GLP-1 Price Per Month Worth It? What You Actually Get

This is the honest question most people are asking. Let’s address it directly.

What the research shows: GLP-1 medications like semaglutide and tirzepatide produce meaningful, sustained weight loss in clinical trials — typically 10–20% of body weight over 12–18 months, depending on the drug and dose. [1] They also improve blood sugar control, reduce cardiovascular risk, and can address fatty liver disease. For a deeper look at the metabolic benefits, see our guide on GLP-1 medications for weight loss and diabetes.

The cost-benefit math at $199–$350/month:

• At $199/month, that’s $2,388/year
• At $350/month, that’s $4,200/year
• Compare that to the long-term costs of obesity-related conditions: diabetes management, cardiovascular medications, joint replacements, and lost productivity

For many people, especially those with metabolic conditions, the math favors treatment — particularly now that prices are approaching more accessible levels.

Who it makes the most sense for:

• Adults with BMI 30+ and at least one metabolic comorbidity
• People who have tried diet and exercise consistently without sustained results
• Those with type 2 diabetes who need both blood sugar and weight management
• Anyone on Medicare, where the $50 copay cap makes costs predictable

Who should think carefully:

• People who can’t commit to the lifestyle changes that maximize GLP-1 results
• Anyone with a history of pancreatitis, thyroid cancer, or certain other conditions (discuss with your doctor)
• Those who would need to stop abruptly due to cost — weight often returns when medication stops

What’s Coming Next: GLP-1 Pricing Trends for 2026 and Beyond

The GLP-1 pricing landscape is moving faster than almost any other drug category. Here’s what’s already confirmed and what’s projected.

Already happening in 2026:

• Medicare $50/month copay cap active from April 2026 [2]
• Novo Nordisk self-pay at $199/month for Wegovy and Ozempic [4]
• Oral Wegovy at ~$150/month for the lowest dose [4]
• TrumpRx platform at $350/month for injectable GLP-1s [3]
• Zepbound starter dose at $299/month through LillyDirect [4]

Announced for 2027:

• Novo Nordisk list price cuts to $675/month — a 50% reduction from current Wegovy pricing [4]
• This follows Eli Lilly overtaking Novo in GLP-1 sales in 2025 and competitive pressure from clinical trial results [4]

Projected (pending FDA approval):

• Oral orforglipron (Lilly’s oral GLP-1 for weight loss) projected at $149–$399/month if approved [3]
• This could be the most significant pricing disruption yet — an oral option at near-$150 entry price

The commercial insurance gap: This remains the biggest unresolved issue. Eli Lilly’s pricing agreements don’t extend to commercial plans, meaning many working-age adults with employer insurance still face high costs or denials. [3] Advocacy and policy pressure may shift this, but it’s not resolved yet.

For people currently uninsured or underinsured, the direct-pay options available today are genuinely the best they’ve ever been. The trajectory suggests further improvement ahead. You can also explore Zepbound vial vs. pen pricing to see how format choices affect your monthly cost.

Frequently Asked Questions About GLP-1 Price Per Month

What is the average GLP-1 price per month in 2026?

It ranges from about $149/month for oral GLP-1 at the lowest dose to $350/month through direct-pay programs like TrumpRx, up to $1,000+ for branded medications without insurance. The most common self-pay options now fall between $199 and $449/month. [1][4]

How much does Wegovy cost per month without insurance?

Through Novo Nordisk’s direct self-pay program, Wegovy is now available at $199/month. Without any savings program, the branded list price exceeds $1,300/month. [4]

How much does Ozempic cost per month?

Ozempic’s self-pay price through Novo Nordisk’s direct program is $199/month. Branded list price without insurance is over $900/month. It’s more commonly covered by insurance than Wegovy because it’s approved for type 2 diabetes. [4]

How much does Zepbound cost per month?

Through Eli Lilly’s LillyDirect program, Zepbound’s starter dose is $299/month and other doses are $449/month. Without savings programs, the list price exceeds $1,000/month. [4]

Does Medicare cover GLP-1 medications for weight loss?

Yes, starting April 2026. Medicare now covers injectable GLP-1s for weight loss with a $50/month copay cap. The base negotiated price is approximately $245/month. [2]

What is the cheapest GLP-1 medication available right now?

Oral semaglutide (oral Wegovy) at approximately $150/month for the lowest dose is currently the most affordable branded GLP-1 entry point. Compounding pharmacy options may be cheaper but carry regulatory and quality risks. [4]

Is the TrumpRx GLP-1 program legitimate?

Yes. The TrumpRx platform is a government-backed direct-to-consumer program offering GLP-1 injections at $350/month, designed to bypass pharmacy benefit managers for cash-pay patients. [3] See your TrumpRx weight loss price guide for full details.

Will GLP-1 prices continue to drop?

Based on current trends, yes. Novo Nordisk has announced 50% list price cuts coming in 2027. Oral GLP-1 options are entering the market at $149–$399/month. Competition between Novo Nordisk and Eli Lilly is driving prices down across the board. [3][4]

Can I get GLP-1 medications through a telehealth provider?

Yes. Many telehealth platforms offer GLP-1 prescriptions with medication fulfillment bundled into monthly pricing. This is often one of the most convenient and cost-competitive access routes for people without adequate insurance coverage.

What happens to my weight if I stop taking GLP-1 medications?

Clinical evidence shows that most people regain a significant portion of lost weight after stopping GLP-1 medications. These are long-term treatments, not short-term fixes. This makes the monthly cost a sustained commitment, not a one-time expense.

Is oral GLP-1 as effective as injectable?

Early data suggests oral semaglutide produces meaningful weight loss, but injectable formulations — particularly tirzepatide (Zepbound) — have shown stronger results in clinical trials. The right choice depends on your individual health profile and what you and your doctor decide together. [1]

Where can I find the best deal on semaglutide specifically?

Your guide to getting the best semaglutide price in 2026 should cover every current option, from manufacturer programs to telehealth platforms to pharmacy comparisons.

Conclusion: What to Do Next

GLP-1 medications are no longer exclusively for people with platinum-tier insurance or unlimited budgets. In 2026, there are legitimate pathways to access these medications for $149 to $350/month — a dramatic shift from where prices stood just two years ago.

Here’s what to do right now:

1. Check your insurance coverage today — call your insurer and ask specifically about GLP-1 coverage for weight management
2. If you’re on Medicare, confirm your eligibility for the $50/month copay program starting April 2026
3. If you’re paying cash, compare Novo’s $199/month self-pay option, LillyDirect’s $299/month Zepbound starter, and the TrumpRx $350/month platform
4. Consider oral options if cost is the primary barrier — $150/month for oral semaglutide is the lowest branded entry point available
5. Talk to your doctor or a telehealth provider to confirm you’re a candidate and get a prescription

Prices are still falling. But if you’ve been waiting for GLP-1 medications to become affordable, the window is open right now — and it’s wider than it’s ever been.

References

[1] GLP-1 Medications Cost Coverage Guide 2026 – [1]

[2] Medicare’s New GLP-1 Pricing Initiative Signals a Shift in Coverage – [2]

[3] GLP-1 Pricing Reform: What’s Changing and Why It Matters for Plan Sponsors – [3]

[4] Novo Slashes GLP-1 Prices Again, Touts New Weight Loss Data on Heels of Lilly Loss – [4]